Literature DB >> 10092508

Cloning and expression of a novel lysophospholipase which structurally resembles lecithin cholesterol acyltransferase.

Y Taniyama1, S Shibata, S Kita, K Horikoshi, H Fuse, H Shirafuji, Y Sumino, M Fujino.   

Abstract

Lecithin cholesterol acyltransferase (LCAT) is the key enzyme in the esterification of plasma cholesterol and in the reverse cholesterol transport on high-density lipoprotein (HDL). We have found a novel LCAT-related gene among differentially expressed cDNA fragments between two types of foam cells derived from THP-1 cells, which are different in cholesterol efflux ability, using a subtractive PCR technique. The deduced 412-amino-acid sequence has 49% amino acid sequence similarity with human LCAT. In contrast to the liver-specific expression of LCAT, mRNA expression of the gene was observed mainly in peripheral tissues including kidney, placenta, pancreas, testis, spleen, heart, and skeletal muscle. The protein exists in human plasma and is probably associated with HDL. Moreover, we discovered that the recombinant protein hydrolyzed lysophosphatidylcholine (lysoPC), a proatherogenic lipid, to glycerophosphorylcholine and a free fatty acid. We have therefore named this novel enzyme LCAT-like lysophospholipase (LLPL), through which a new catabolic pathway for lysoPC on lipoproteins could be elucidated. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10092508     DOI: 10.1006/bbrc.1999.0411

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

Review 1.  Group XV phospholipase A₂, a lysosomal phospholipase A₂.

Authors:  James A Shayman; Robert Kelly; Jessica Kollmeyer; Yongqun He; Akira Abe
Journal:  Prog Lipid Res       Date:  2010-11-11       Impact factor: 16.195

Review 2.  The metabolic serine hydrolases and their functions in mammalian physiology and disease.

Authors:  Jonathan Z Long; Benjamin F Cravatt
Journal:  Chem Rev       Date:  2011-06-23       Impact factor: 60.622

3.  Genetically Compromising Phospholipid Metabolism Limits Candida albicans' Virulence.

Authors:  Dorothy Wong; James Plumb; Hosamiddine Talab; Mouhamad Kurdi; Keshav Pokhrel; Peter Oelkers
Journal:  Mycopathologia       Date:  2019-01-28       Impact factor: 2.574

4.  Alteration of Lysophosphatidylcholine-Related Metabolic Parameters in the Plasma of Mice with Experimental Sepsis.

Authors:  Won-Gyun Ahn; Jun-Sub Jung; Hyeok Yil Kwon; Dong-Keun Song
Journal:  Inflammation       Date:  2017-04       Impact factor: 4.092

5.  The measurement of lysosomal phospholipase A2 activity in plasma.

Authors:  Akira Abe; Robert Kelly; James A Shayman
Journal:  J Lipid Res       Date:  2010-04-21       Impact factor: 5.922

Review 6.  Lysosomal phospholipase A2.

Authors:  James A Shayman; John J G Tesmer
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2018-08-02       Impact factor: 4.698

Review 7.  Lysophosphatidic acid signaling in airway epithelium: role in airway inflammation and remodeling.

Authors:  Yutong Zhao; Viswanathan Natarajan
Journal:  Cell Signal       Date:  2008-10-26       Impact factor: 4.315

8.  Cloning and functional characterization of a phospholipid:diacylglycerol acyltransferase from Arabidopsis.

Authors:  Ulf Ståhl; Anders S Carlsson; Marit Lenman; Anders Dahlqvist; Bangquan Huang; Walentyna Banas; Antoni Banas; Sten Stymne
Journal:  Plant Physiol       Date:  2004-07-09       Impact factor: 8.340

Review 9.  A turn in the road: How studies on the pharmacology of glucosylceramide synthase inhibitors led to the identification of a lysosomal phospholipase A2 with ceramide transacylase activity.

Authors:  James A Shayman; Akira Abe; Miki Hiraoka
Journal:  Glycoconj J       Date:  2004       Impact factor: 2.916

10.  The role of negatively charged lipids in lysosomal phospholipase A2 function.

Authors:  Akira Abe; James A Shayman
Journal:  J Lipid Res       Date:  2009-03-25       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.